Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

724 ARTÍCULOS , VIENDO DEL 661 AL 675

The Mild Behavioral Impairment Checklist for Parkinson's Disease: An Ancillary Instrument in Cognitive Assessment

Pinilla-Monsalve GD, Song YP, Hanganu A, Ismail Z, Monchi O.

Mov Disord Clin Pract. 2026 Jan;13(1):108-119. doi: 10.1002/mdc3.70243. Epub 2025 Aug 4.

The Management of Parkinson's Disease Before, during and after Pregnancy-an MDS Scientific Issues Committee Review

Lehn AC, Lee JY, Sciacca G, Patterson S, Morton A, Pun P, Kamel WA, Picillo M, Post B, Tan EK, Capato T, Bloem BR, Auffret M, Oosterbaan AM, Kapelle W, Bruno MK, Kalia LV, Kordower JH, Berg D.

Mov Disord Clin Pract. 2026 Jan;13(1):44-59. doi: 10.1002/mdc3.70289. Epub 2025 Aug 20.

Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease

Desjardins C, Grimaldi S, Luo S, Yu L, Goetz CG, Stebbins GT, Martinez-Martin P, Kurtis MM, Mestre TA, Sanchez-Ferro A, Tosin MHS, Balestrino R, Lin CR, Gasca-Salas C, Witjas T, Colin O, Maltete D, Defebvre L, Giordana C, Charif M, Thiriez C, Laurencin C, Tir M, Dupont G, Remy P, Tranchant C, Drapier S, Samier A, Benatru I, Sambin S, Corvol JC, Khelifi F, Fabbri M, Rascol O; NS‐Part Cohort study group and the MDS COA Translation Steering Committee.

Mov Disord Clin Pract. 2026 Feb;13(2):575-579. doi: 10.1002/mdc3.70323. Epub 2025 Sep 1.

A Holistic Wellness Prescription for Parkinson's Disease: Evidence-Based Perspectives and Unmet Needs

Subramanian I, Ricciardi L, Schrag A, Appel-Cresswell S, Kola S, Domingos JM, Pickut BA, Dahodwala N, Bocoum A, Falup-Pecurariu C, Bronner G, Pontone GM, Mischley LK, Garretto NS, Modugno N, Dolhun R, Wijeratne T, Tull V, McDaniels B, Chaudhuri KR; International Parkinson; Movement Disorder Society Task Force on Wellness.

Mov Disord Clin Pract. 2026 Mar;13(3):631-646. doi: 10.1002/mdc3.70381. Epub 2025 Oct 14.

Intracranial Neural Biomarkers of Psychiatric Symptoms and Their Utility for Guiding Neuromodulation Therapy: A Systematic Review

Kabotyanski KE, Provenza NR, Sheth SA.

Biol Psychiatry. 2026 May 15;99(10):909-922. doi: 10.1016/j.biopsych.2025.10.005. Epub 2025 Oct 13.

Transcranial Ultrasound Stimulation of Internal Globus Pallidus Region and Motor Cortex in Parkinson's Disease

Lin YY, Raies N, Grippe T, Gunraj CA, Sarica C, Saha UK, Bhattacharya A, Darmani G, Chen R.

Mov Disord. 2026 Feb;41(2):416-425. doi: 10.1002/mds.70095. Epub 2025 Oct 23.

Absence of STN Neuronal Activity during MER in DBS Surgery: Diagnostic and Clinical Implications

Umemura A, Oyama G, Shimo Y, Iwamuro H, Nakajima A, Shimizu M, Hatano T, Kondo A, Hattori N.

Stereotact Funct Neurosurg. 2026;104(2):81-90. doi: 10.1159/000549010. Epub 2025 Oct 23.

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

Papathoma E, Tsitsi P, Vijiaratnam N, Aquino C, Duma SR, Kovacs N, Okeng'o KL, Shukla AW, Bhidayasiri R, Mestre TA, Ferro AS, Espay AJ, Tosin MHS, Skorvanek M, Markaki I.

Mov Disord Clin Pract. 2026 May;13(5):1124-1146. doi: 10.1002/mdc3.70410. Epub 2025 Oct 29.

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases

Painous C, Fernández M, Cámara A, Alba-Arbalat S, Soto M, Brenlla C, Muñoz E, Pérez-Soriano A, Valldeoriola F, Martí MJ, Tolosa E, Garrido A, Sánchez-Gómez A, Maragall L, Camós-Carreras A, Tió M, Martín N, Basora M, Buongiorno M, Pont-Sunyer MC, Delgado T, Planas-Ballvé A, Caballol N, Ávila A, Vilas D, Jaumà S, Marco C, de Fàbregues O, Matos N, Mas A, Mas N, Aragonés JM, Bejr-Kasem H, Navarro-Otano J, Montori-Palacín E, Balasa M, Sarto J, Borrego-Écija S, Roldán P, Perissinotti A, Molina-Porcel L, Aldecoa I, Pérez-Montesino J, de Mena L, Naranjo L, Ruiz-García R, Compta Y.

Mov Disord. 2026 Feb;41(2):500-508. doi: 10.1002/mds.70086. Epub 2025 Oct 29.

Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review

Virameteekul S, Shin C, Hirczy SS, Sarva H, Paul SS, Maetzler W, Mirelman A, Schneider RB, Hausdorff JM, Vizcarra JA, Klucken J, Monje MHG, Mancini M, Bonato P, Nieuwboer A, Horak FB, Rochester L, Sanchez-Ferro A, Zatti C, Fabbri M, Mestre TA, Reilmann R, Espay AJ, Bloem BR, Pilotto A, Bhidayasiri R; MDS Technology Study Group.

Mov Disord. 2026 Jan;41(1):40-62. doi: 10.1002/mds.70097. Epub 2025 Nov 1.

Glucocerebrosidase Target Engagement and Therapeutic Plasma and Cerebrospinal Fluid Levels After GT-02287 Administration in Healthy Volunteers

Pozzi R, De Sciscio M, Bosetti M, Cano-Crespo S, Taylor J, Ignoni T, Hannestad J.

Mov Disord. 2026 Feb;41(2):522-527. doi: 10.1002/mds.70111. Epub 2025 Nov 5.

Validation of the Psychosis and Hallucinations Questionnaire in Lewy Body Dementia

Gunawardana CW, Burke PGR, Matar E, Lewis SJG.

J Geriatr Psychiatry Neurol. 2026 Jul;39(4):368-379. doi: 10.1177/08919887251395314. Epub 2025 Nov 7.

Can wearable sensor based measures of gait accurately reflect Parkinson's disease severity? A systematic review and meta-analysis

Youssef H, Sabıroğlu M, Mahmoud Abdel-Rahman S, Hasanin T, Manay M, Gönül MN, Mancini M, Del Din S, Vural A.

Parkinsonism Relat Disord. 2026 Jan;142:108108. doi: 10.1016/j.parkreldis.2025.108108. Epub 2025 Nov 8.

Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants

Pokorny R, Ryan JM, Abd-Elaziz K, van den Berg F, Rabiner E, Searle GE, Schneider M, Wiessner C, Stallaert JF, Permanne B, Quattropani A, Beher D.

Mov Disord. 2026 Feb;41(2):436-444. doi: 10.1002/mds.70104. Epub 2025 Nov 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias